Prolistem® is a fertility support solution that can significantly enhance the chances of sperm production for men with non-obstructive azoospermia (primary testicular failure). Prolistem® is patented and FDA-certified.
Prolistem® does it like rebooting your smartphone to fix glitches. Our six-month program has two steps: first, we create the perfect setting for sperm production by temporarily lowering testosterone. Then, in phase two, we bring testosterone back to normal, promoting robust and healthy sperm production. It’s like hitting a refresh button for your fertility journey!
Prolistem is the culmination of a lot of hard work, research, and thinking. Our main goal in all our research is to find solutions that can help other people. Thirty years ago, men with azoospermia had no options for having children. We studied, we searched, and finally, we found a way. Prolistem helps men with this problem make their families whole. It’s a new chance, a fresh start, a reason to smile.
We are honored to participate in the highly anticipated ESHRE 2024 Conference, a global stage where the...
We are honored to participate in the prestigious ASRM 2024 Conference in Denver, Colorado, a cornerstone...
Prolistem® Joins the ASRM 2024 Conference in Denver We are thrilled to announce that Prolistem® will...
The Prolistem treatment has emerged as a breakthrough for men grappling with non-obstructive azoospermia,...
He main point of the article “Inhibition of Spermatogonial Differentiation by Testosterone”...
We are thrilled to announce that Prolistem®, developed by Medhija LLC, has received approval from the...
Get in touch and let us know how we can help
Unlike most fertility supplements designed for oligospermia (low sperm count), Prolistem is uniquely formulated to address azoospermia, a condition marked by the complete absence of sperm in semen. By targeting the underlying causes of impaired sperm production, Prolistem works through temporary testosterone modulation to restore spermatogenesis in cases with viable stem cells.
Azoospermia is complex and often requires specialized care. Prolistem offers a groundbreaking, science-backed solution, providing hope for those with limited options, when guided by a fertility specialist.
In 2012, the Department of Urology at Presbyterian Hospital (New York) published an article on hormonal treatments before TESE, stating:
“Men with non-obstructive azoospermia and hypogonadism often respond to hormonal therapy with an increase in testosterone levels, but neither baseline testosterone levels nor response to hormonal therapy appears to affect overall sperm retrieval, clinical pregnancy, or live birth rates.”
Reinforcing this, the 2023 Canadian Urology Association (CUA) guidelines emphasize that hormonal therapy is not an effective solution for non-obstructive azoospermia. They state that such treatments do not improve sperm retrieval rates during microTESE and are not recommended in these cases. https://pmc.ncbi.nlm.nih.gov/articles/PMC10426417/
Prolistem is generally considered safe, and it aims to minimize side effects. However, like any dietary supplement or medication, individual reactions may vary. It is important to note that certain individuals with specific health conditions may be more sensitive to the effects of Prolistem®. Such conditions may include heart failure, heart disease, fluid retention, high blood pressure (hypertension), diabetes, kidney disease, the use of antidepressant medications, and liver disease.
If an individual has any of these conditions or is taking medications for them, it is advisable to consult with a healthcare professional before starting Prolistem® or any other supplement. A healthcare professional can evaluate the individual’s specific situation, consider potential interactions or sensitivities, and provide personalized recommendations.
Overall, it is crucial to prioritize safety and seek guidance from healthcare professionals to ensure the most appropriate and beneficial approach to individual health concerns.
Prolistem, a patented formula, has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Copyright © 2023 Prolistem®
Prolistem, a patented formula, has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Copyright © 2023 Prolistem®
